Rethink IL-5 in CRSwNP and comorbidity: from T2 key pathological processes to Real Life impact with Mepolizumab

      Rethink IL-5 in CRSwNP and comorbidity: from T2 key pathological processes to Real Life impact with Mepolizumab
      Moderatore: G. Ottaviano
      Relatori: A. Vultaggio, E. De Corso, E. Cantone

      con il contributo non condizionante di GLAXOSMITHKLINE

      Share This Event
      Event Details
      Add to Calendar
      G. Ottaviano
      E. De Corso
      E. Cantone
      A. Vultaggio
      Event Details
      Add to Calendar

      This site uses cookies. Find out more about cookies and how you can refuse them.

      I Accept